CCL19 and breast cancer: To begin testing for the functional significance of native CXCR4-CCR7 complexes in breast cancer, we assessed the ability of CXCL12, CCL19 or in combination to inhibit the forskolin-induced increase in cAMP production in MMTV-PyMT primary mammary cells (Supplementary Figure S2C).